{"id":685470,"date":"2026-04-03T19:06:04","date_gmt":"2026-04-03T19:06:04","guid":{"rendered":"https:\/\/microscopemedia.com\/?p=685470"},"modified":"2026-04-03T19:06:04","modified_gmt":"2026-04-03T19:06:04","slug":"persoanele-care-au-mai-multe-sanse-sa-supravietuiasca-cancerului-au-urmatoarele-caracteristici-potrivit-unui-studiu-amplu","status":"publish","type":"post","link":"https:\/\/microscopemedia.com\/?p=685470","title":{"rendered":"Persoanele care au mai multe \u0219anse s\u0103 supravie\u021buiasc\u0103 cancerului au urm\u0103toarele caracteristici, potrivit unui studiu amplu"},"content":{"rendered":"<div><img decoding=\"async\" src=\"https:\/\/microscopemedia.com\/wp-content\/uploads\/2026\/04\/persoanele-care-au-mai-multe-sanse-sa-supravietuiasca-cancerului-au-urmatoarele-caracteristici-potrivit-unui-studiu-amplu.jpg\" class=\"ff-og-image-inserted\"><\/div>\n<p id=\"p-0\">Publicat\u0103 \u00een \u201eJournal of the National Cancer Institute\u201d (JNCI), cercetarea a identificat diferen\u021be consistente \u00eentre pacien\u021bii cu cancer de sex masculin \u0219i feminin, at\u00e2t \u00een ceea ce prive\u0219te supravie\u021buirea, c\u00e2t \u0219i toxicitatea tratamentului. Astfel, pacientele aveau un risc de deces cu 21 % mai mic dec\u00e2t pacien\u021bii de sex masculin, dar un risc de toxicitate sever\u0103 cu 12 % mai mare, scrie <a href=\"https:\/\/www.eleconomista.es\/salud-bienestar\/enfermedades\/noticias\/13850174\/03\/26\/las-personas-que-tienen-mas-probabilidades-de-sobrevivir-al-cancer-tienen-las-siguientes-caracteristicas-segun-un-gran-estudio.html\" target=\"_blank\" rel=\"noopener\">El Economista<\/a>.<\/p>\n<p id=\"p-1\">Aceste diferen\u021be bazate pe sex au fost \u00een mare m\u0103sur\u0103 consistente \u00een 12 tipuri de tumori solide avansate, precum \u0219i \u00een diferite modalit\u0103\u021bi de tratament, inclusiv chimioterapie, terapii \u021bintite \u0219i imunoterapie, ceea ce sugereaz\u0103 c\u0103 se datoreaz\u0103 unor mecanisme biologice subiacente, \u0219i nu doar efectelor specifice ale medicamentelor.<\/p>\n<p id=\"p-2\">\u00cen loc s\u0103 se concentreze pe modul \u00een care tratamentele specifice \u00eempotriva cancerului afecteaz\u0103 diferit b\u0103rba\u021bii \u0219i femeile, abordarea tradi\u021bional\u0103, studiul a analizat dac\u0103 sexul \u00een sine prezice supravie\u021buirea \u0219i toxicitatea, independent de tipul de tratament.<\/p>\n<h2 id=\"chapter-0\">Aspecte principale<\/h2>\n<p id=\"p-3\">Autorul principal, doctorul Natansh Modi, afirm\u0103 c\u0103 studiul ofer\u0103 unele dintre cele mai clare dovezi de p\u00e2n\u0103 acum c\u0103 sexul biologic este un factor predictiv esen\u021bial pentru rezultatele tratamentului cancerului.<\/p>\n<p id=\"p-4\">\u201eSexul este un factor biologic fundamental care influen\u021beaz\u0103 func\u021bia imunitar\u0103, metabolismul medicamentelor, compozi\u021bia corporal\u0103 \u0219i biologia tumorilor\u201d, afirm\u0103 acesta.<\/p>\n<p id=\"p-5\">\u201eCu toate acestea, \u00een ciuda recomand\u0103rilor de lung\u0103 durat\u0103 ale organismelor de reglementare \u0219i de finan\u021bare de a raporta rezultatele \u00een func\u021bie de sex, \u00een multe studii acesta este \u00eenc\u0103 tratat ca o chestiune secundar\u0103 \u0219i rareori este luat \u00een considerare riscul de baz\u0103 sau utilizat pentru a personaliza deciziile de tratament. Studiul nostru abordeaz\u0103 aceast\u0103 problem\u0103 analiz\u00e2nd dac\u0103 sexul \u00een sine prezice supravie\u021buirea \u0219i toxicitatea \u00eentr-o gam\u0103 larg\u0103 de cancere \u0219i terapii\u201d, continu\u0103 medicul.<\/p>\n<p id=\"p-6\">De asemenea, el subliniaz\u0103 c\u0103 \u201e<strong>rezultatele au fost clare: femeile aveau un risc de deces cu 21 % mai mic dec\u00e2t b\u0103rba\u021bii, dar se confruntau \u0219i cu un risc cu 12 % mai mare de a suferi efecte secundare grave<\/strong>. Femeile au demonstrat un avantaj \u00een ceea ce prive\u0219te supravie\u021buirea, dar cu pre\u021bul unei toxicit\u0103\u021bi severe mai ridicate\u201d, subliniaz\u0103 el.<\/p>\n<p id=\"p-7\">Studiul a analizat date de la peste 20.000 de pacien\u021bi cu cancer din 39 de studii clinice care au sus\u021binut aprob\u0103rile FDA din Statele Unite \u00eentre 2011 \u0219i 2021 \u0219i a acoperit 12 tipuri de tumori solide avansate, inclusiv cancer pulmonar, colorectal, melanom \u0219i cancer de s\u00e2n.<\/p>\n<h2 id=\"chapter-1\">Mai multe detalii<\/h2>\n<p id=\"p-8\">Descoperirile au implica\u021bii importante pentru modul \u00een care sunt evaluate \u0219i prescrise medicamentele, \u00eent\u0103rind necesitatea de a raporta \u0219i de a ac\u021biona sistematic pe baza dovezilor specifice fiec\u0103rui sex \u00een cercetarea clinic\u0103.<\/p>\n<p id=\"p-9\">Din acest motiv, cercet\u0103torii cer ca sexul biologic s\u0103 fie recunoscut ca un factor prognostic fundamental \u00een oncologie, at\u00e2t \u00een studiile clinice, c\u00e2t \u0219i \u00een \u00eengrijirea oncologic\u0103 de zi cu zi.<\/p>\n<p id=\"p-10\">\u201eEste vorba despre \u00eembun\u0103t\u0103\u021birea rezultatelor pentru to\u021bi pacien\u021bii cu cancer. Dac\u0103 femeile tr\u0103iesc mai mult, dar experimenteaz\u0103 efecte secundare mai grave, trebuie s\u0103 recunoa\u0219tem acest lucru \u0219i s\u0103 ac\u021bion\u0103m \u00een consecin\u021b\u0103. \u00cen acela\u0219i timp, trebuie s\u0103 \u00een\u021belegem mai bine de ce pacien\u021bii de sex masculin par s\u0103 aib\u0103 o rat\u0103 de supravie\u021buire mai sc\u0103zut\u0103\u201d, afirm\u0103 doctorul Modi.<\/p>\n<p id=\"p-11\">Echipa sus\u021bine c\u0103 este nevoie de mai multe cercet\u0103ri pentru a \u00een\u021belege mecanismele biologice care determin\u0103 aceste diferen\u021be, inclusiv expunerea la medicamente, reglarea imunitar\u0103, influen\u021bele hormonale \u0219i compozi\u021bia corporal\u0103.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Publicat\u0103 \u00een \u201eJournal of the National Cancer Institute\u201d (JNCI), cercetarea a identificat diferen\u021be consistente \u00eentre pacien\u021bii cu cancer de sex masculin \u0219i feminin, at\u00e2t \u00een ceea ce prive\u0219te supravie\u021buirea, c\u00e2t &hellip; <a href=\"https:\/\/microscopemedia.com\/?p=685470\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":685471,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/685470"}],"collection":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=685470"}],"version-history":[{"count":0,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/685470\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/media\/685471"}],"wp:attachment":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=685470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=685470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=685470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}